"Human papillomavirus 18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of human papillomavirus especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.
| Descriptor ID |
D052161
|
| MeSH Number(s) |
B04.280.210.655.050.618 B04.613.204.655.050.618
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human papillomavirus 18".
Below are MeSH descriptors whose meaning is more specific than "Human papillomavirus 18".
This graph shows the total number of publications written about "Human papillomavirus 18" by people in this website by year, and whether "Human papillomavirus 18" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2017 | 8 | 5 | 13 |
| 2018 | 3 | 5 | 8 |
| 2019 | 3 | 1 | 4 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Human papillomavirus 18" by people in Profiles.
-
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia. Clin Infect Dis. 2020 06 10; 70(12):2582-2590.
-
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. Am J Epidemiol. 2020 04 02; 189(4):265-276.
-
Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions. Vaccine. 2019 08 23; 37(36):5460-5465.
-
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial. Cancer Med. 2019 10; 8(14):6195-6211.
-
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women. Sci China Life Sci. 2020 Apr; 63(4):582-591.
-
Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province. Women Health. 2019 Nov-Dec; 59(10):1105-1117.
-
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study. Cancer. 2019 01 15; 125(2):239-248.
-
Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study. Sex Transm Infect. 2019 03; 95(2):140-144.
-
Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid. Vaccine. 2018 10 29; 36(45):6761-6771.
-
A systematic literature review of studies reporting human papillomavirus (HPV) prevalence in esophageal carcinoma over 36 years (1982-2017). Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep; 27(3):127-136.